Table 1.
Involvement | Prevalence (%) |
---|---|
Cranial neuropathies | 50–75 |
II | 15 |
VII | 25–50 |
VIII | 10–20 |
Meningeal disease | 10–20 |
Hydrocephalus | 10 |
Parenchymal disease | 50 |
Endocrinopathy | 10–15 |
Mass lesion | 5–10 |
Encephalopathy/Vasculopathy | 5–10 |
Seizures | 5–10 |
Neuropathy | 15 |
Myopathy | 15 |
The prevalence shown is that among all patients with neurosarcoidosis.
Adapted from Stern.19